chronic kidney disease

FDA declines to approve FibroGen's anemia drug
Yahoo/Reuters
Wed, 08/11/21 - 12:07 pm
FibroGen
FDA
anemia
chronic kidney disease
roxadustat
Ardelyx chops a third of its staff after stock-crushing failure in chronic kidney disease
Endpoints
Wed, 08/4/21 - 11:00 am
Ardelyx
chronic kidney disease
layoffs
tenapanor
FDA turns down Ardelyx’s chronic kidney disease drug and asks for another trial
MedCity News
Thu, 07/29/21 - 11:06 pm
Ardelyx
tenapanor
FDA
chronic kidney disease
FibroGen slides after FDA posted documents ahead of AdCom meeting on Roxadustat
Seeking Alpha
Tue, 07/13/21 - 11:06 am
FibroGen
FDA
roxadustat
advisory panels
chronic kidney disease
Novo Nordisk continues pushing beyond diabetes, netting PhII win for former Corvidia kidney program
Endpoints
Tue, 05/18/21 - 11:00 am
Novo Nordisk
chronic kidney disease
clinical trials
ziltivekimab
AstraZeneca's big CKD promises come to fruition as Farxiga wins approval in patients regardless of diabetes status
Endpoints
Mon, 05/3/21 - 10:45 am
AstraZeneca
Farxiga
FDA
chronic kidney disease
AstraZeneca's diabetes drug Farxiga nabs coveted kidney disease nod, way ahead of rival Jardiance
Fierce Pharma
Sat, 05/1/21 - 09:23 pm
AstraZeneca
chronic kidney disease
FDA
Farxiga
AstraZeneca's Farxiga gets rough FDA review date for groundbreaking move into chronic kidney disease
Endpoints
Wed, 01/6/21 - 11:03 am
AstraZeneca
Farxiga
FDA
chronic kidney disease
Astellas, FibroGen get approval in Japan for Evrenzo to treat anaemia of CKD in adult patients not on dialysis
Pharmaceutical Business Review
Sun, 11/29/20 - 02:10 pm
Astellas
FibroGen
Japan
Evrenzo
chronic kidney disease
AHA 2020 – sotagliflozin wins come too late for Lexicon
EP Vantage
Tue, 11/17/20 - 10:45 am
Lexicon Pharmaceuticals
sotagliflozin
AHA
heart failure
chronic kidney disease
FibroGen Provides More Support for Roxadustat in Anemia Associated with Kidney Disease
BioSpace
Mon, 10/26/20 - 11:15 pm
FibroGen
roxadustat
ASN
chronic kidney disease
With approval in sight, Vifor expands deal for partner's anti-itch drug
BioPharma Dive
Tue, 10/20/20 - 09:58 pm
Cara Therapeutics
Vifor
dialysis
chronic kidney disease
The FDA hands Farxiga 'breakthrough' status in CKD, clearing path for AstraZeneca's much-touted therapy
Endpoints
Sun, 10/4/20 - 12:18 am
AstraZeneca
chronic kidney disease
FDA
breakthrough therapy
Farxiga
5 FDA approval decisions to watch in the 4th quarter
BioPharma Dive
Wed, 09/30/20 - 10:45 am
FDA
drug approvals
vaccines
Pfizer
Moderna Therapeutics
COVID-19
Regeneron
EB3
ebola virus
Alkermes
ALKS-3831
schizophrenia
bipolar disorder
Bristol-Myers Squibb
liso-cel
non-Hodgkin lymphoma
roxadustat
FibroGen
chronic kidney disease
ESC 2020 – Farxiga impresses in chronic kidney disease
EP Vantage
Mon, 08/31/20 - 10:14 am
ESC
Farxiga
chronic kidney disease
diabetes
clinical trials
AstraZeneca
Tricida sinks as FDA rejection raises prospect of new trial
Fierce Biotech
Tue, 08/25/20 - 10:33 am
Tricida
metabolic acidosis
chronic kidney disease
clinical trials
FDA
Veverimer
Novo Nordisk taps Evotec to target chronic kidney disease
Fierce Biotech
Tue, 08/18/20 - 11:14 am
Novo Nordisk
chronic kidney disease
Evotec
After stopping Farxiga trial early, AstraZeneca declares success in CKD treatment
Endpoints
Tue, 07/28/20 - 11:17 am
AstraZeneca
Farxiga
clinical trials
chronic kidney disease
GSK’s kidney disease anemia drug approved in Japan, taking on Astellas’ rival
Pharmaforum
Mon, 06/29/20 - 06:21 pm
GSK
anemia
chronic kidney disease
daprodustat
Japan
Astellas
Kyowa Kirin
ADA: AstraZeneca's diabetes-fighter Farxiga cuts risk of fast decline in kidney function
Fierce Pharma
Mon, 06/15/20 - 11:10 pm
AstraZeneca
Farxiga
chronic kidney disease
ADA
diabetes

Pages